We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EDBL:NASDAQEdible Garden AG Incorporated Analysis

Data as of 2026-03-30 - not real-time

$0.91

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Edible Garden AG Incorporated is trading at $0.91, barely above its technical support of $0.88, while the 20‑day RSI sits at a bearish 20 and the MACD remains in a negative crossover, signaling strong short‑term downside pressure. Volume is increasing despite a market cap of only $672k, but the stock’s 30‑day volatility of 145% and a beta of 0.76 amplify price swings, and the recent max drawdown of -98% underscores the extreme risk. Fundamental metrics are equally concerning: operating margin is –126%, profit margin –115%, and both operating and free cash flow are deeply negative, while debt‑to‑equity stands at 26.55, indicating a heavily leveraged balance sheet with a negative book value per share. Recent news notes that the company has regained Nasdaq bid‑price compliance and secured chain‑wide distribution at The Fresh Market, offering a modest operational catalyst, yet the financial distress remains dominant.
Given the confluence of weak technical signals, severe profitability deficits, and high volatility, the stock appears fundamentally distressed with limited upside. While the distribution partnership could provide a foothold for revenue growth, the lack of cash generation, negative earnings, and thin liquidity suggest that any recovery would be long‑term and highly uncertain, making the current price more reflective of risk than of intrinsic value.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • RSI below 30 and bearish MACD indicating oversold momentum
  • Price hovering at technical support with limited upside
  • Extreme volatility and thin liquidity increasing trade risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential revenue uplift from Fresh Market distribution
  • Continued negative cash flows and high leverage
  • Uncertainty around achieving profitability

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental restructuring needed to reverse operating losses
  • Possible upside if turnaround succeeds and margins improve
  • Persistent risk from debt load and negative book value

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin-115.44%
P/E Ratio0.0
ROE-179.10%
ROA-55.26%
Debt/Equity26.55
P/B Ratio-0.1
Op. Cash Flow$-10897000
Free Cash Flow$-5794030

Technical Analysis

TrendBearish
RSI20.4
Support$0.88
Resistance$3.25
MA 20$2.06
MA 50$3.31
MA 200$14.40
MACDBearish
VolumeIncreasing
Fear & Greed Index68.3

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.76
Volatility145.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.